G PROSPECT: web-based clinical decision support programme (www.postoppain.org), which aims to formulate robust evidence-based recommendations for procedure-specific postoperative pain management. G Initiated by an expert Working Group of surgeons and anaesthesiologists. G The aim of this systematic review, which was part of a larger review investigating postoperative pain management following thoracotomy (total included studies = 169; total excluded studies = 163), was to compare the efficacy and safety of paravertebral block (PV) and thoracic epidural (TE) analgesia for the management of post-thoracotomy pain. 
Materials and Methods

PV (LA) vs. control
G There was a significant benefit of PV (LA) treatment over control for reducing VAS pain scores at rest, see Figure  2 ; the effect was evident from the early postoperative period (0-6 h) through to the third postoperative day. G PV (LA) treatment was also significantly superior to control for reducing VAS pain scores on coughing 1 and on movement 2 at the time points recorded, see Figure 2 .
Meta-analyses:
G PV (LA) was superior to control for reducing pain scores at rest on: -day 1 (four studies, including two arms of one study, WMD -12.28 mm, p=0.0007) -day 3 (three studies, including two arms of one study, WMD -18.25 mm, p=0.009) G There were no significant differences between groups:
-at 8 h (three studies, including two arms of one study, WMD -11.89 mm, p=0.11)
-on day 2 (four studies, including two arms of one study, WMD -7.13 mm, p=0.36) TE (LA + opioid) vs. control G There was a significant benefit of TE (LA + opioid) treatment over control for reducing VAS pain scores at rest and on coughing, see Figure 3 . G This effect was evident at most time points recorded, with the exception of Day 2 and 8-12 h for pain at rest and on coughing, respectively; at those time points, half of the studies showed a significant benefit of TE (LA + opioid) treatment over control. G TE (LA + opioid) treatment was also significantly superior to control for reducing VAS pain scores on movement at all time points recorded. G One study that did not specify the time of assessment 3 found no significant difference between groups for pain on movement.
G TE (LA + opioid) was superior to control for reducing pain scores at rest:
-at 12 h (one study plus two arms of one study, WMD -16.14 mm, p<0.0001) 
TE (LA ± opioid) vs. PV (LA ± opioid)
G TE (LA) and PV (LA) were largely comparable for reducing VAS pain scores both at rest and on coughing. G There were no studies assessing VAS pain scores on movement for this particular comparison. G TE (LA + opioid) is commonly used in clinical practice 4 and it would be valuable to compare this technique with PV (LA). G Only three studies included opioid in the LA solution in one or both groups [5] [6] [7] ; these studies showed mixed results. G In the early postoperative period, PV (LA) and TE (LA) showed comparable effects on pain scores, see Figure  4a ; studies including opioid in the LA solution showed a tendency towards higher pain scores in the PV group. G Mean or median pain scores were comparable overall between TE (LA ± opioid) and PV (LA ± opioid) on day 1/at 24 h, see Figure 4b . G Quantitative analysis of pain score data was not performed because there was heterogeneity in study design between studies that presented data suitable for meta-analysis. out of four studies found significantly improved pulmonary function in the PV (LA) group compared with the TE (LA) group. G The other two studies 8, 11 reported no significant differences between groups for pulmonary function outcomes.
A recent systematic review comparing the analgesic efficacy and side-effects of paravertebral vs. epidural blockade also found that the two techniques were comparable for reducing pain scores, but PV (LA ± opioid) was associated with improvements in pulmonary function and a reduction in side-effects, compared with TE (LA ± opioid) 13 .
Conclusions
This systematic review found that: G PV (LA) and TE (LA + opioid) were both effective for reducing pain after thoracotomy compared with control. G When comparing PV (LA) with TE (LA), there was no overall benefit of either technique for reducing pain scores. G PV (LA) was associated with fewer side-effects and improved pulmonary function compared with TE (LA). G There were very few studies comparing PV (LA) with TE (LA + opioid), which currently prevents evaluation of the 'gold standard' for post-thoracotomy pain. 
